DOCSLIB.ORG

Present HLA-B-Like Peptides Rhesus Macaque MHC Class I Molecules

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Present HLA-B-Like Peptides Rhesus Macaque MHC Class I Molecules Rhesus Macaque MHC Class I Molecules Present HLA-B-Like Peptides Heather D. Hickman-Miller, Wilfried Bardet, Angela Gilb, Angela D. Luis, Kenneth W. Jackson, David I. Watkins and This information is current as William H. Hildebrand of September 24, 2021. J Immunol 2005; 175:367-375; ; doi: 10.4049/jimmunol.175.1.367 http://www.jimmunol.org/content/175/1/367 Downloaded from References This article cites 63 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/175/1/367.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Rhesus Macaque MHC Class I Molecules Present HLA-B-Like Peptides1 Heather D. Hickman-Miller,2* Wilfried Bardet,* Angela Gilb,* Angela D. Luis,* Kenneth W. Jackson,* David I. Watkins,† and William H. Hildebrand3* SIV-infected Indian rhesus macaques (Macaca mulatta) are an important animal model for humans infected with HIV. Under- standing macaque (M. mulatta class I (Mamu)) MHC class I-peptide binding facilitates the comparison of SIV- and HIV-specific cellular immune responses. In this study, we characterized the endogenous peptide-binding properties of three Mamu-A (A*02, A*08, A*11) and three Mamu-B (B*01, B*03, B*12) class I molecules. Motif comparisons revealed that five of the six macaque class I molecules (A*02, A*08, A*11, B*01, and B*03) have peptide-binding motifs similar to those of human class I molecules. Of the 65 macaque endogenous peptide ligands that we sequenced by tandem mass spectroscopy, 5 were previously eluted from HLA class I molecules. Nonamers predominated among the individual ligands, and both the motifs and the individual ligands indicated P2, Downloaded from P9, and various ancillary anchors. Interestingly, peptide binding of the Mamu-A and Mamu-B molecules exhibited cross-species peptide-presentation overlap primarily with HLA-B molecules. Indeed, all of the macaque class I molecules appeared HLA-B-like in peptide presentation. Remarkably, the overlap in macaque- and HLA-peptide presentation occurred despite divergent class I peptide-binding grooves. Macaque and human class I differing by up to 42 aa (13–23%) within the ␣-1 and ␣-2 domains, including substantial divergence within specificity pockets A-F, bound the same endogenous peptide. Therefore, endogenous peptide char- acterization indicates that macaque class I molecules may be the functional equivalents of HLA-B molecules. The Journal of http://www.jimmunol.org/ Immunology, 2005, 175: 367–375. lass I MHC molecules mediate antiviral immune re- tion confirms the important role of class I MHC in mediating an- sponses by first binding short viral peptides (7–14 aa) tiviral immune responses and has led to the development of mo- C within the infected host cell and then transiting to the cell lecular class I typing methods and the application of synthetic surface where they present their peptide cargo to CTL (1–6). Vi- peptide binding assays for macaque MHC molecules (24–28). ruses have developed a myriad of means to avoid the presentation With the recent discovery of as many as 16 active rhesus MHC of viral peptides by class I MHC molecules (7–11), and as an class I gene loci, assays for determining macaque class I MHC by guest on September 24, 2021 immune countermeasure, individuals within each mammalian spe- gene types and peptide-binding specificities will play an expanded cies tend to differ in their class I MHC genotype and phenotype role in characterizing antiviral immune responses in this (12–15). The polymorphism that distinguishes one class I molecule primate (29). from the next alters the peptide ligands that can be accommodated In humans, class I MHC peptide-binding specificities have been within a class I molecule’s peptide-binding groove (16, 17). There- empirically elucidated through a combination of 1) the Edman se- fore, MHC class I molecules tend to differ functionally from in- quencing of pooled endogenous ligands, 2) the mass spectrometric dividual to individual within a species. sequencing of individual endogenous ligands, and 3) competitive Animal models represent a valuable tool for studying host- synthetic peptide-binding assays (30–32). By comparison, the pep- pathogen relationships, and the Indian rhesus macaque represents tide specificity of MHC class I molecules in the Indian rhesus an important animal model for a number of viruses that infect macaque has been derived almost exclusively from in vitro com- humans (18–23). Notably, infection of macaques with SIV results petitive-binding studies with synthetic peptides (10, 26, 27, 33, in an AIDS-like illness similar to that of humans infected with HIV 34). Peptide-binding assays delineate the major peptide anchors (24). Use of the Indian rhesus macaque as a model for HIV infec- preferred by a given class I molecule and have led to predictions of peptides that are presented in vivo by a particular molecule. Sequencing of endogenous ligands complements synthetic pep- *Department of Microbiology and Immunology, University of Oklahoma Health Sci- ences Center, Oklahoma City, OK 73104; and †Wisconsin Regional Primate Center, tide-binding data by demonstrating that ligands of a particular se- University of Wisconsin, Madison, WI 53715 quence endogenously arise, traffic, survive, and are loaded into Received for publication February 11, 2005. Accepted for publication April 13, 2005. MHC molecules within a cell. The costs of publication of this article were defrayed in part by the payment of page To characterize endogenous peptide-binding specificities for In- charges. This article must therefore be hereby marked advertisement in accordance dian rhesus macaque class I molecules, and to better relate the with 18 U.S.C. Section 1734 solely to indicate this fact. peptide-binding properties of rhesus monkey and human class I 1 This work was supported by a National Institutes of Health Grant 5R24RR015371 (to D.I.W.). H.D.H.-M. was supported by National Institutes of Health Training Grant molecules, we have established endogenous-peptide motifs for six T32AI07633. macaque class I molecules. Additionally, we sequenced Ͼ60 en- 2 Current address: Laboratory of Viral Diseases, National Institute of Allergy and dogenously loaded peptide ligands, representing the first compre- Infectious Diseases, National Institutes of Health, Bethesda, MD. hensive set of naturally loaded MHC class I ligands identified in 3 Address correspondence and reprint requests to Dr. William H. Hildebrand, Depart- nonhuman primates. Like the human, the macaque class I mole- ment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, 975 N.E. 10th Street, Oklahoma City, OK, 73104. E-mail address: William- cules bound primarily nonamers with distinct P2 and P9 anchor [email protected] preferences. Surprisingly, the macaque and human class I MHC Copyright © 2005 by The American Association of Immunologists, Inc. 0022-1767/05/$02.00 368 HLA-B-LIKE MACAQUE CLASS I molecules that bound similar (and in some cases identical) pep- ing identical ligands. Dashes in the alignments indicate identity. Noniden- tides did so despite divergent peptide-binding grooves. Even a sub- tities are indicated by the single letter amino acid code of the differing stantial number of nonconservative amino acid changes within residue. specificity pockets did not abrogate the binding of similar peptides Results by particular pairs of macaque and human class I molecules. Fi- Endogenous peptide motifs of six macaque molecules exhibit nally, the three Macaca mulatta class I-A (Mamu-A)4 and three properties similar to HLA molecules Mamu-B class I molecules studied here are all HLA-B functional equivalents. The implications of this similarity in peptide binding To characterize the peptides endogenously bound by Indian rhesus is discussed. macaque class I molecules and to compare their peptide repertoires to those in human MHC molecules, we produced transfectants of Materials and Methods sMamu-A*02, -A*08, -A*11, -B*01, -B*03, and -B*12 in the hu- Mamu protein production man, class I-negative cell line 721.221 (35). Through hollow-fiber bioreactor culture of stable transfectants, we produced ϳ25 mg of Cloned DNA for Mamu-A*02, -A*08, -B*01, and -B*03 was amplified using the 5MamuKE (5Ј-GGGCGAATTCCCGCCGCCACCATGGCGCCCCGAA each molecule, purified molecules by affinity chromatography, and CCC-3Ј) and 3VLDLRHIN (5Ј-CCGCAAGCTTTCAGGCAAGGTCGTCG isolated and purified ϳ0.5 mg of naturally bound peptides. We TCGGTGCTGACGACGCTCCATCTCAGGGTGAGGGG-3Ј) or 5Mamu1KE then recorded peptide motifs for each of the molecules in accor- Ј Ј (5 -GGGCGAATTCCCGCCGCCACCATGCGGGTCATGGCTCC-3 ) and dance with previously published procedures for human class I mol- 3VLDLRHIN (5Ј-CCGCAAGCTTTCAGGCAAGGTCGTCGTCGGTGCT GACGACGCTCCATCTCAGGGTGAGGGG-3Ј) for Mamu-A*11 and ecules (39) (Fig. 1). -B*12. Both primer pairs resulted in an amplicon of ϳ900 bp corresponding In terms of the location and number of anchor residues within Downloaded from to a truncated protein lacking the cytoplasmic and transmembrane domains; motifs, the macaque endogenous peptides were remarkably similar the latter primer pair also encoded the epitope tag SVVSTDDDLA which was to those found in human molecules.
Load more

Recommended publications
  • MUC4/MUC16/Muc20high Signature As a Marker of Poor Prognostic for Pancreatic, Colon and Stomach Cancers
    Jonckheere and Van Seuningen J Transl Med (2018) 16:259 https://doi.org/10.1186/s12967-018-1632-2 Journal of Translational Medicine RESEARCH Open Access Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large‑scale genomic databases: MUC4/MUC16/ MUC20 signature is associated with poor survival in human carcinomas Nicolas Jonckheere* and Isabelle Van Seuningen* Abstract Background: MUC4 is a membrane-bound mucin that promotes carcinogenetic progression and is often proposed as a promising biomarker for various carcinomas. In this manuscript, we analyzed large scale genomic datasets in order to evaluate MUC4 expression, identify genes that are correlated with MUC4 and propose new signatures as a prognostic marker of epithelial cancers. Methods: Using cBioportal or SurvExpress tools, we studied MUC4 expression in large-scale genomic public datasets of human cancer (the cancer genome atlas, TCGA) and cancer cell line encyclopedia (CCLE). Results: We identifed 187 co-expressed genes for which the expression is correlated with MUC4 expression. Gene ontology analysis showed they are notably involved in cell adhesion, cell–cell junctions, glycosylation and cell signal- ing. In addition, we showed that MUC4 expression is correlated with MUC16 and MUC20, two other membrane-bound mucins. We showed that MUC4 expression is associated with a poorer overall survival in TCGA cancers with diferent localizations including pancreatic cancer, bladder cancer, colon cancer, lung adenocarcinoma, lung squamous adeno- carcinoma, skin cancer and stomach cancer. We showed that the combination of MUC4, MUC16 and MUC20 signature is associated with statistically signifcant reduced overall survival and increased hazard ratio in pancreatic, colon and stomach cancer.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Research2007herschkowitzetvolume Al
    Open Access Research2007HerschkowitzetVolume al. 8, Issue 5, Article R76 Identification of conserved gene expression features between comment murine mammary carcinoma models and human breast tumors Jason I Herschkowitz¤*†, Karl Simin¤‡, Victor J Weigman§, Igor Mikaelian¶, Jerry Usary*¥, Zhiyuan Hu*¥, Karen E Rasmussen*¥, Laundette P Jones#, Shahin Assefnia#, Subhashini Chandrasekharan¥, Michael G Backlund†, Yuzhi Yin#, Andrey I Khramtsov**, Roy Bastein††, John Quackenbush††, Robert I Glazer#, Powel H Brown‡‡, Jeffrey E Green§§, Levy Kopelovich, reviews Priscilla A Furth#, Juan P Palazzo, Olufunmilayo I Olopade, Philip S Bernard††, Gary A Churchill¶, Terry Van Dyke*¥ and Charles M Perou*¥ Addresses: *Lineberger Comprehensive Cancer Center. †Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ‡Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA. reports §Department of Biology and Program in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ¶The Jackson Laboratory, Bar Harbor, ME 04609, USA. ¥Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. #Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA. **Department of Pathology, University of Chicago, Chicago, IL 60637, USA. ††Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. ‡‡Baylor College of Medicine, Houston, TX 77030, USA. §§Transgenic Oncogenesis Group, Laboratory of Cancer Biology and Genetics. Chemoprevention Agent Development Research Group, National Cancer Institute, Bethesda, MD 20892, USA. Department of Pathology, Thomas Jefferson University, Philadelphia, PA 19107, USA. Section of Hematology/Oncology, Department of Medicine, Committees on Genetics and Cancer Biology, University of Chicago, Chicago, IL 60637, USA.
    [Show full text]
  • NIH Public Access Author Manuscript Dev Biol
    NIH Public Access Author Manuscript Dev Biol. Author manuscript; available in PMC 2013 January 1. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Dev Biol. 2012 January 1; 361(1): 68±78. doi:10.1016/j.ydbio.2011.10.004. Regulation of intrahepatic biliary duct morphogenesis by Claudin 15-like b Isla D. Cheung1, Michel Bagnat1,2, Taylur P. Ma3, Anirban Datta4, Kimberley Evason1,5, John C. Moore6, Nathan Lawson6, Keith E. Mostov4, Cecilia B. Moens3, and Didier Y.R. Stainier1,* 1Department of Biochemistry and Biophysics; Programs in Developmental and Stem Cell Biology, Genetics and Human Genetics; Liver Center, Diabetes Center, and Institute for Regeneration Medicine; University of California, San Francisco, CA 94158, USA 3HHMI and Division of Basic Science, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA 4Department of Anatomy, University of California, San Francisco, CA 94143, USA 5Department of Pathology, University of California, San Francisco, CA 94110, USA 6Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, MA 01605, USA Abstract The intrahepatic biliary ducts transport bile produced by the hepatocytes out of the liver. Defects in biliary cell differentiation and biliary duct remodeling cause a variety of congenital diseases including Alagille Syndrome and polycystic liver disease. While the molecular pathways regulating biliary cell differentiation have received increasing attention (Lemaigre, 2010), less is known about the cellular behavior underlying biliary duct remodeling. Here, we have identified a novel gene, claudin 15-like b (cldn15lb), which exhibits a unique and dynamic expression pattern in the hepatocytes and biliary epithelial cells in zebrafish.
    [Show full text]
  • Novel Compound Heterozygote Mutations of TJP2 in a Chinese
    Ge et al. BMC Medical Genetics (2019) 20:18 https://doi.org/10.1186/s12881-019-0753-7 CASEREPORT Open Access Novel compound heterozygote mutations of TJP2 in a Chinese child with progressive cholestatic liver disease Ting Ge, Xinyue Zhang, Yongmei Xiao, Yizhong Wang* and Ting Zhang* Abstract Background: Progressive familial intrahepatic cholestasis (PFIC) is a group of genetic autosomal recessive disorders that predominantly affects young children and results in early-onset progressive liver damage. Several types of PFIC were defined based on different genetic aetiologies in last decades. Case presentation: Here, we report a Chinese young child diagnosed as PFIC with variants in tight junction protein 2 (TJP2). The patient was affected by a long history of jaundice, pruritus, and failure to thrive. Highly elevated level of serum total bile acid (TBA) and normal levels of gamma-glutamyltransferase (GGT) were observed at hospitalization. The patient’s clinical symptoms could be alleviated by administration of ursodeoxycholic acid. Genetic testing by next generation sequencing (NGS) found novel compound heterozygote mutations c.2448 + 1G > C/c.2639delC (p.T880Sfs*12) in TJP2, which were inherited from her mother and father, respectively. Both mutations were predicted to abolish TJP2 protein translation, and neither has previously been identified. Conclusion: We report a Chinese female PFIC child with novel compound heterozygous mutations of TJP2.Genetic testing by NGS is valuable in the clinical diagnosis of hereditary liver disease. Keywords: Autosomal recessive disorder, Child, Compound heterozygote mutations, Progressive cholestatic liver disease, TJP2 Background in adenosine triphosphate-binding cassette subfamily B Progressive familial intrahepatic cholestasis (PFIC), first de- member 4 (ABCB4), which encodes the multidrug scribed in 1969, is a group of genetic autosomal recessive resistance P-glycoprotein 3 protein (MDR3) leads to disorders that are characterized by fluctuating jaundice, the development of PFIC 3 [5].
    [Show full text]
  • A Novel Homozygous USP53 Splicing Variant Disrupting the Gene Function That Causes Cholestasis Phenotype and Review of the Literature
    A Novel Homozygous USP53 Splicing Variant Disrupting the Gene Function that Causes Cholestasis Phenotype and Review of the Literature ALPER GEZDIRICI ( [email protected] ) Basaksehir Cam and Sakura City Hospital https://orcid.org/0000-0002-2432-9279 ÖZLEM KALAYCIK ŞENGÜL İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi: Istanbul Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi MUSTAFA DOĞAN Basaksehir Cam and Sakura City Hospital BANU YILMAZ ÖZGÜVEN Basaksehir Cam and Sakura City Hospital EKREM AKBULUT Malatya Turgut Özal Üniversitesi: Malatya Turgut Ozal Universitesi Research Article Keywords: USP53, cholestasis, homology modeling, whole exome sequencing Posted Date: August 12th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-762230/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/19 Abstract Background: Hereditary cholestasis is a heterogeneous group of liver diseases that mostly show autosomal recessive inheritance. The phenotype of cholestasis is highly variable. Molecular genetic testing offers a useful approach to differentiate different types of cholestasis because some symptoms and ndings overlap. Biallelic variants in USP53 have recently been reported in cholestasis phenotype. In this study we aim to characterize clinical ndings and biological insights on a novel USP53 splice variant causing cholestasis phenotype and review of the literature. Methods and Results: We reported a novel splice variant (NM_019050.2:c.238-1G>C) in the USP53 gene via whole exome sequencing in a patient with cholestasis phenotype. This variant was conrmed by sanger sequencing and as a result of family segregation analysis; it was found to be a heterozygous state in the parents and the other healthy elder brother of our patient.
    [Show full text]
  • Protective Effects of Propionate Upon the Blood–Brain Barrier
    bioRxiv preprint doi: https://doi.org/10.1101/170548; this version posted February 7, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Microbiome–host systems interactions: Protective effects of propionate upon 2 the blood–brain barrier 3 4 Lesley Hoyles1*, Tom Snelling1, Umm-Kulthum Umlai1, Jeremy K. Nicholson1, Simon 5 R. Carding2, 3, Robert C. Glen1, 4 & Simon McArthur5* 6 7 1Division of Integrative Systems Medicine and Digestive Disease, Department of 8 Surgery and Cancer, Imperial College London, UK 9 2Norwich Medical School, University of East Anglia, UK 10 3The Gut Health and Food Safety Research Programme, The Quadram Institute, 11 Norwich Research Park, Norwich, UK 12 4Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, 13 Cambridge, UK 14 5Institute of Dentistry, Barts & the London School of Medicine & Dentistry, Blizard 15 Institute, Queen Mary University of London, London, UK 16 17 *Corresponding authors: Lesley Hoyles, [email protected]; Simon 18 McArthur, [email protected] 19 Running title: Propionate affects the blood–brain barrier 20 Abbreviations: ADHD, attention-deficit hyperactivity disorder; ASD, autism spectrum 21 disorder; BBB, blood–brain barrier; CNS, central nervous system; FFAR, free fatty acid 22 receptor; KEGG, Kyoto Encyclopaedia of Genes and Genomes; GO, Gene Ontology; 1 bioRxiv preprint doi: https://doi.org/10.1101/170548; this version posted February 7, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Novel Protein Pathways in Development and Progression of Pulmonary Sarcoidosis Maneesh Bhargava1*, K
    www.nature.com/scientificreports OPEN Novel protein pathways in development and progression of pulmonary sarcoidosis Maneesh Bhargava1*, K. J. Viken1, B. Barkes2, T. J. Grifn3, M. Gillespie2, P. D. Jagtap3, R. Sajulga3, E. J. Peterson4, H. E. Dincer1, L. Li2, C. I. Restrepo2, B. P. O’Connor5, T. E. Fingerlin5, D. M. Perlman1 & L. A. Maier2 Pulmonary involvement occurs in up to 95% of sarcoidosis cases. In this pilot study, we examine lung compartment-specifc protein expression to identify pathways linked to development and progression of pulmonary sarcoidosis. We characterized bronchoalveolar lavage (BAL) cells and fuid (BALF) proteins in recently diagnosed sarcoidosis cases. We identifed 4,306 proteins in BAL cells, of which 272 proteins were diferentially expressed in sarcoidosis compared to controls. These proteins map to novel pathways such as integrin-linked kinase and IL-8 signaling and previously implicated pathways in sarcoidosis, including phagosome maturation, clathrin-mediated endocytic signaling and redox balance. In the BALF, the diferentially expressed proteins map to several pathways identifed in the BAL cells. The diferentially expressed BALF proteins also map to aryl hydrocarbon signaling, communication between innate and adaptive immune response, integrin, PTEN and phospholipase C signaling, serotonin and tryptophan metabolism, autophagy, and B cell receptor signaling. Additional pathways that were diferent between progressive and non-progressive sarcoidosis in the BALF included CD28 signaling and PFKFB4 signaling. Our studies demonstrate the power of contemporary proteomics to reveal novel mechanisms operational in sarcoidosis. Application of our workfows in well-phenotyped large cohorts maybe benefcial to identify biomarkers for diagnosis and prognosis and therapeutically tenable molecular mechanisms.
    [Show full text]
  • View: Regulation of Epithelial Na Channel Traffick- Ing
    BASIC RESEARCH www.jasn.org Phosphoproteomic Profiling Reveals Vasopressin- Regulated Phosphorylation Sites in Collecting Duct Amar D. Bansal,* Jason D. Hoffert,* Trairak Pisitkun,* Shelly Hwang,* Chung-Lin Chou,* Emily S. Boja,† Guanghui Wang,† and Mark A. Knepper* *Epithelial Systems Biology Laboratory, and †Proteomics Core Facility, Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland ABSTRACT Protein phosphorylation is an important component of vasopressin signaling in the renal collecting duct, but the database of known phosphoproteins is incomplete. We used tandem mass spectrometry to identify vasopressin-regulated phosphorylation events in isolated rat inner medullary collecting duct (IMCD) suspensions. Using multiple search algorithms to identify the phosphopeptides from spectral data, we expanded the size of the existing collecting duct phosphoproteome database from 367 to 1187 entries. Label-free quantification in vasopressin- and vehicle-treated samples detected a significant change in the phosphorylation of 29 of 530 quantified phosphopeptides. The targets include important structural, regulatory, and transporter proteins. The vasopressin-regulated sites included two known sites (Ser-486 and Ser-499) present in the urea channel UT-A1 and one previously unknown site (Ser-84) on vasopressin-sensitive urea channels UT-A1 and UT-A3. In vitro assays using synthetic peptides showed that purified protein kinase A (PKA) could phosphorylate all three sites, and immunoblotting confirmed the PKA dependence of Ser-84 and Ser-486 phosphorylation. These results expand the known list of collecting duct phosphoproteins and highlight the utility of targeted phosphoproteomic approaches. J Am Soc Nephrol 21: 303–315, 2010. doi: 10.1681/ASN.2009070728 Vasopressin plays a central role in collecting duct In a previous study,17 we used tandem mass physiology.
    [Show full text]
  • Effect of Graphene and Graphene Oxide on Airway Barrier and Differential Phosphorylation of Proteins in Tight and Adherens Junction Pathways
    nanomaterials Article Effect of Graphene and Graphene Oxide on Airway Barrier and Differential Phosphorylation of Proteins in Tight and Adherens Junction Pathways Sofie Van Den Broucke 1, Jeroen A. J. Vanoirbeek 2 , Rita Derua 3, Peter H. M. Hoet 1,2,* and Manosij Ghosh 1,2,* 1 Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, 3000 Leuven, Belgium; vandenbroucke.sofi[email protected] 2 Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KU Leuven, 3000 Leuven, Belgium; [email protected] 3 Laboratory of Protein Phosphorylation and Proteomics, KU Leuven, 3000 Leuven, Belgium; [email protected] * Correspondence: [email protected] (P.H.M.H.); [email protected] (M.G.) Abstract: Via inhalation we are continuously exposed to environmental and occupational irritants which can induce adverse health effects, such as irritant-induced asthma (IIA). The airway epithelium forms the first barrier encountered by these agents. We investigated the effect of environmental and occupational irritants on the airway epithelial barrier in vitro. The airway epithelial barrier was mimicked using a coculture model, consisting of bronchial epithelial cells (16HBE) and monocytes (THP-1) seeded on the apical side of a permeable support, and human lung microvascular endothelial cells (HLMVEC) grown on the basal side. Upon exposure to graphene (G) and graphene oxide Citation: Van Den Broucke, S.; (GO) in a suspension with fetal calf serum (FCS), ammonium persulfate (AP), sodium persulfate Vanoirbeek, J.A.J.; Derua, R.; Hoet, (SP) and hypochlorite (ClO−), the transepithelial electrical resistance (TEER) and flux of fluorescent P.H.M.; Ghosh, M.
    [Show full text]
  • S12920-021-01005-X.Pdf
    Tkatchenko and Tkatchenko BMC Med Genomics (2021) 14:153 https://doi.org/10.1186/s12920-021-01005-x RESEARCH Open Access Genome-wide analysis of retinal transcriptome reveals common genetic network underlying perception of contrast and optical defocus detection Tatiana V. Tkatchenko1 and Andrei V. Tkatchenko1,2,3* Abstract Background: Refractive eye development is regulated by optical defocus in a process of emmetropization. Excessive exposure to negative optical defocus often leads to the development of myopia. However, it is still largely unknown how optical defocus is detected by the retina. Methods: Here, we used genome-wide RNA-sequencing to conduct analysis of the retinal gene expression network underlying contrast perception and refractive eye development. Results: We report that the genetic network subserving contrast perception plays an important role in optical defo- cus detection and emmetropization. Our results demonstrate an interaction between contrast perception, the retinal circadian clock pathway and the signaling pathway underlying optical defocus detection. We also observe that the relative majority of genes causing human myopia are involved in the processing of optical defocus. Conclusions: Together, our results support the hypothesis that optical defocus is perceived by the retina using con- trast as a proxy and provide new insights into molecular signaling underlying refractive eye development. Keywords: Refractive eye development, Myopia, Contrast perception, Optical defocus, Circadian rhythms, Signaling pathways, Gene expression profling, Genetic network, RNA-seq Background compensate for imposed defocus very accurately by Refractive eye development is controlled by both envi- modulating the growth of the posterior segment of the ronmental and genetic factors, which determine the eye via a developmental mechanism called bidirectional optical geometry of the eye and its refractive state by a emmetropization by the sign of optical defocus (BESOD), process called emmetropization [1–8].
    [Show full text]
  • Gene Expression in Donor Corneal Endothelium
    OPHTHALMIC MOLECULAR GENETICS SECTION EDITOR: EDWIN M. STONE, MD, PhD Gene Expression in Donor Corneal Endothelium John D. Gottsch, MD; Gerami D. Seitzman, MD; Elliott H. Margulies, PhD; Amanda L. Bowers, BA; Allison J. Michels, BA; Saurabh Saha, MD, PhD; Albert S. Jun, MD, PhD; Walter J. Stark, MD; Sammy H. Liu, PhD Objective: To report gene expression profiles of nor- synthase F0 subunit 6, carbonic anhydrase XII, 12S ribo- mal human corneal endothelium with microarray analy- somal RNA, and ferritin, heavy polypeptide 1. Thirty-four sis and serial analysis of gene expression (SAGE). percent of the transcripts (n=1616) were specific to the corneal endothelium, when compared with other pub- Methods: Corneal endothelium was removed from nor- licly available SAGE libraries. The 5 most abundant unique mal human corneas obtained from eye banks. Total RNA tags were keratin 12, angiopoietinlike factor, annexin A8, was isolated and SAGE analysis was performed. The same and 2 tags with no match to the database. Many endothe- RNA source was used to construct a complementary DNA lial pump function enzymes were confirmed, including sev- library that was hybridized to microarrays containing eral plasma membrane Na+/K+ adenosine triphosphatases 12558 transcripts. and a recently reported bicarbonate transporter. Results: A total of 9530 SAGE tags were sequenced, rep- Conclusions: Corneal endothelial gene expression pro- resenting 4724 unique tags. Microarray analysis identified files by the current analysis provide an understanding of 542 distinct transcripts. A database of human corneal en- endothelial metabolism, structure, and function; enable dothelial gene expression was compiled. Of the SAGE tags, comparisons to diseased endothelium; and provide base- 1720 matched known genes, 478 corresponded to expressed line data that may lead to the discovery of novel endo- sequence tags, and 2526 had no known match to public da- thelial genes.
    [Show full text]